Coronavirus Disease 2019 (COVID‑19)

Coronavirus Disease 2019 (COVID‑19) is the indication for 32 drugs in DrugBank. It is covered by 92 curated, structured indications.

Also known as: 2019 Novel Coronavirus · 2019-nCoV · Coronavirus Disease 2019 · Coronavirus Disease (COVID-19) · CoVID-19
Classified under: Infections
Respiratory Tract Diseases
Indicated drugs: Anakinra
Andusomeran
AstraZeneca COVID-19 Vaccine
Baricitinib
BNT162B2 Omicron (LP.8.1)
Cilgavimab
CX-046684
CX-052075
Davesomeran
Elasomeran
Ensitrelvir
Famtozinameran
Imdevimab
Imelasomeran
Janssen COVID-19 Vaccine
mRNA-1283
Nuvaxovid
Pemivibart
Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccine
Raxtozinameran
Regdanvimab
Remdesivir
Riltozinameran
SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains)
Sipavibart
and 7 more with a free account

Resolves to

Vocabularies

MeSHM000732426ICD-10U07.1SNOMED CT840539006MedDRA10084268UMLSC5203670

What you can answer from here — as of September 27, 2026

32Indicated drugsWith each drug's targets and mechanism

92Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

4,430Clinical trialsPhase, status and sponsor resolved per trial

36Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Coronavirus Disease 2019 (COVID‑19) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.